Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

Nexvet Biopharma Ord (NVET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 06/30

(Values in U.S. thousands)

	06-2016	06-2015	06-2014	06-2013
Assets
Current Assets
Cash & Cash Equivalents	31,481	52,033	30,041	483
Other current assets	2,201	3,301	2,404	1,010
TOTAL	$34,962	$55,941	$33,088	$1,867

Non-Current Assets
PPE Net	4,908	549	514	47
Intangibles	74	19	2	0
Other Non-Current Assets	380	163	0	0
TOTAL	$5,362	$731	$516	$47

Total Assets	$40,324	$56,672	$33,604	$1,914

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	1,729	658	870	679
Accrued Expenses	3,295	2,352	2,299	552
TOTAL	$5,047	$3,033	$3,197	$1,231

Non-Current Liabilities
Deferred Revenues	23	23	N/A	N/A
Other Non-Current Liabilities	104	0	5,435	0
TOTAL	$141	$61	$5,538	$N/A

Total Liabilities	$5,188	$3,094	$8,735	$1,231

Shareholders' Equity
Shares Outstanding, K	11,703	11,452	N/A	N/A
Common Shares	1,446	1,426	126	124
Retained earnings	-43,020	-23,655	-11,798	-5,088
Other shareholders' equity	-5,320	-4,468	34,199	3,668
TOTAL	$35,136	$53,578	$24,869	$683

Total Liabilities And Equity	$40,324	$56,672	$33,604	$1,914